4//SEC Filing
Gross Paul Edward 4
Accession 0000899243-22-020945
CIK 0001466301other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:15 PM ET
Size
9.5 KB
Accession
0000899243-22-020945
Insider Transaction Report
Form 4
Gross Paul Edward
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+5,062→ 87,018 total - Sale
Common Stock
2022-06-02$0.64/sh−2,403$1,544→ 84,615 total - Exercise/Conversion
Restricted Stock Units
2022-06-01+5,062→ 55,688 total→ Common Stock (5,062 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $0.642368 to $0.644300. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
Related Parties
1- filerCIK 0001766329
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:15 PM ET
- Size
- 9.5 KB